Dr. Ola Myklebost
Dr. Myklebost's research has concentrated on gene aberrations frequently found in samples from sarcoma patients and what these can tell us about the mechanisms involved in sarcoma development and progression. Several of these have been copied into relevant experimental cell models to understand the mechanisms better, and to try to develop this understanding into new therapeutic options. He has also participated in a number of international sarcoma consortia (see osteosarcomaresearch.org and liposarcomaresearch.org). Dr. Myklebost was appointed professor at the Institute for Molecular Biosciences at the University of Oslo in 1998, and has for five years been an advisor to the Norwegian Board of Health on medical applications of biotechnology in medicine. He initiated and was a leader of the Norwegian Microarray Consortium (now Genomics Consortium) a service platform for genomic technologies for Norwegian scientists for 10 years. He is assistant director of the Oslo Cancer Stem Cell Innovation Centre, and head of the Norwegian Cancer Genomics Consortium. Dr. Myklebost joined the Liddy Shriver Sarcoma Initiative's Medical Advisory and Editorial Board in October 2012. Copyright © 2012 Liddy Shriver Sarcoma Initiative. |